[Double-blind randomized clinical study on treatment of warts with a fluorouracil-containing topical preparation (author's transl)]
- PMID: 7013310
[Double-blind randomized clinical study on treatment of warts with a fluorouracil-containing topical preparation (author's transl)]
Abstract
In a double blind trial 60 patients were treated with a salicylic acid-containing product against warts (Verrumal) on basis fluorouracil in comparison to placebo. The trial demonstrated a statistically significantly better result for the verum preparation than for the placebo without fluorouracil and without salicylic acid. This product against warts is, therefore, indicated if operative methods are not applicable or refused by the patient.
Similar articles
-
5-Fluorouracil in the treatment of common warts of the hands. A double-blind study.Br J Dermatol. 1975 Jan;92(1):89-91. Br J Dermatol. 1975. PMID: 1098688 Clinical Trial.
-
Topical 5-fluorouracil has no additional benefit in treating common warts with cryotherapy: a single-centre, double-blind, randomized, placebo-controlled trial.Clin Exp Dermatol. 2006 May;31(3):394-7. doi: 10.1111/j.1365-2230.2006.02105.x. Clin Exp Dermatol. 2006. PMID: 16681586 Clinical Trial.
-
[Treatment of condyloma acuminatum with 0.5% 5-fluorouracil-solution, A double-blind clinical trial].Z Hautkr. 1982 Jun 1;57(11):810-6. Z Hautkr. 1982. PMID: 7048776 Clinical Trial. German.
-
Treatment of common warts with an intralesional mixture of 5-fluorouracil, lidocaine, and epinephrine: a prospective placebo-controlled, double-blind randomized trial.Dermatol Surg. 2008 May;34(5):656-9. doi: 10.1111/j.1524-4725.2007.34123.x. Epub 2008 Feb 6. Dermatol Surg. 2008. PMID: 18261100 Clinical Trial.
-
[5-Fluorouracil--recent advances in clinical studies].Gan To Kagaku Ryoho. 1987 Aug;14(8):2612-5. Gan To Kagaku Ryoho. 1987. PMID: 3304171 Review. Japanese. No abstract available.
Cited by
-
5-FU for genital warts in non-immunocompromised individuals.Cochrane Database Syst Rev. 2010 Apr 14;2010(4):CD006562. doi: 10.1002/14651858.CD006562.pub2. Cochrane Database Syst Rev. 2010. PMID: 20393949 Free PMC article.
-
Safety and Efficacy of FIT039 for Verruca Vulgaris: A Placebo-Controlled, Phase I/II Randomized Controlled Trial.JID Innov. 2021 May 20;1(3):100026. doi: 10.1016/j.xjidi.2021.100026. eCollection 2021 Sep. JID Innov. 2021. PMID: 34909725 Free PMC article. Clinical Trial.
-
Topical treatments for cutaneous warts.Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD001781. doi: 10.1002/14651858.CD001781.pub3. Cochrane Database Syst Rev. 2012. PMID: 22972052 Free PMC article.
-
Local treatments for cutaneous warts: systematic review.BMJ. 2002 Aug 31;325(7362):461. BMJ. 2002. PMID: 12202325 Free PMC article.
-
The efficacy of a cyclin dependent kinase 9 (CDK9) inhibitor, FIT039, on verruca vulgaris: study protocol for a randomized controlled trial.Trials. 2019 Aug 9;20(1):489. doi: 10.1186/s13063-019-3570-6. Trials. 2019. PMID: 31399147 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical